Cannabis use in United States has mirrored policy changes
May 29, 2024
A nadir in use was reported in 1992, with partial recovery through 2008 and substantial increases thereafter.
Nonwhite adults with cognitive impairment more likely to live in polluted areas
May 21, 2024
The authors say that clinical trials should consider environmental exposures and injustices.
US Justice Department moves to reclassify weed as less risky drug
May 17, 2024
The US Justice Department on Thursday moved to reclassify marijuana as a less dangerous drug, setting the stage for a significant shift in the nation’s drug policy.
Heatwave exposure linked to considerable mortality burden
May 14, 2024
Geographic disparities were seen in the temporal change of the heatwave-related mortality burden.
Virtual reality therapy can augment depression treatment
May 13, 2024
Extended reality-enhanced behavioral activation (XR-BA) may be a feasible enhancement to traditional BA for major depressive disorder.
Majority of US adults give healthcare system a ‘D’ for handling mental health
May 08, 2024
Cost, finding a provider and stigma are top barriers to receiving treatment.
Biden administration could reclassify marijuana as less risky drug
May 01, 2024
The Justice Department has recommended that marijuana be reclassified as a less dangerous drug, a move that signals a significant shift in US drug policy.
USPSTF recommends breast cancer screening for women aged 40 to 75 years
Apr 30, 2024
Insufficient evidence was seen for screening older women and for supplemental screening for women with dense breasts.
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
Seafood consumption tied to ‘forever chemical’ exposure risk
Apr 24, 2024
Consumers of seafood purchased in a local northeastern US market may be exposed to potentially risky PFAS concentrations.